
==== Front
Cureus
Cureus
2168-8184
Cureus
2168-8184
Cureus Palo Alto (CA)

10.7759/cureus.67455
Neurology
Pediatrics
Infectious Disease
Central Hypercapnia in a Neonate With Parechovirus Infection
Muacevic Alexander
Adler John R
Tahata Ryo 1
Yamano Akio 1
Zuiki Masashi 2
Ishihara Yasunori 1
Akioka Shinji 2
1 Pediatrics, Fukui Aiiku Hospital, Fukui, JPN
2 Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, JPN
Ryo Tahata r-tahata@koto.kpu-m.ac.jp
22 8 2024
8 2024
16 8 e6745512 8 2024
Copyright © 2024, Tahata et al.
2024
Tahata et al.
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article is available from https://www.cureus.com/articles/245136-central-hypercapnia-in-a-neonate-with-parechovirus-infection
Human parechovirus infections in newborns often affect the central nervous system. It is common in children after infancy for it to be a cause of the common cold or be asymptomatic, but an infection in infancy often causes a central nervous system infection. Herein, we present the case of a nine-day-old infant who developed hypercapnia without any involvement of respiratory lesions. She showed no hypoxia or circulatory abnormalities. A high-flow nasal cannula relieved hypercapnia and consequent respiratory acidosis, suggesting that the hypercapnia was due to central ventilation failure with central nervous system infection despite no abnormalities on brain magnetic resonance imaging. Accurate diagnosis and intervention of ventilatory failure, which is a central nervous system dysfunction, is important in hypercapnia associated with parechovirus infection.

high-flow nasal cannula (hfnc)
neonates
hypercapnia
human parechovirus
central neurological dysfunction
ventilation failure
==== Body
pmcIntroduction

Human parechovirus (HPeV) infections occur predominantly in early childhood and present with various clinical manifestations [1]. Most cases are subclinical and have good prognoses [2]; however, infections during the neonatal period or early infancy can lead to severe organ damage such as encephalitis, meningitis, and sepsis-like syndrome [3,4]. Moreover, encephalitis can lead to neurological sequelae and fatal outcomes [5,6].

Herein, we report a case of HPeV infection in a neonate who presented with hypercapnia and tachypnea. Hypercapnia, a rare manifestation of HPeV infection, is caused by a central ventilation defect without airway involvement [7]. In this case, a high-flow nasal cannula (HFNC) with ambient air relieved the ventilatory disturbance. This case report suggests that disturbances in the central nervous system are variably manifested in neonatal HPeV infection such as central respiratory failure. Adequate understanding of the pathogenesis and appropriate treatment are essential to prevent organ damage in such cases.

Case presentation

A nine-day-old girl was referred to our hospital with a fever. She fed poorly the night before and developed a fever on the day of admission. She was born following 39 weeks and 6 days of gestation via vaginal delivery. Her birth weight was 3024 g and her Apgar scores were 8 at 1 minute and 9 at 5 minutes. The mother had no apparent infection or abnormal course during the pregnancy and delivery. She was discharged from the maternity hospital when she was five days old.

On admission, the patient weighed 3090 g; her temperature was 38.7°C, her pulse rate was 168 beats/min, systolic and diastolic blood pressures were 78 and 43 mmHg, respectively, and her respiratory rate was 50 breaths/min. Although her respiration was shallow, retractive, or forced breathing, as well as abnormal breaths, such as wheezing, were not observed. Transcutaneous oxygen saturation was 95% in ambient air. Although appearing to be not doing well, she was capable of crying as usual and had no body movement impairments. Her peripheral skin was cold but not cyanotic, anemic, or mottled. Auscultation revealed no abnormal cardiac or respiratory sounds. Her abdomen was slightly distended; however, intestinal peristalsis was audible.

Venous blood gas analysis revealed respiratory acidosis (pH 7.275), mildly elevated partial pressure of CO2 (pCO2) of 54.0 mmHg, bicarbonate (HCO3-) of 21.5 mmHg, BE of -2.3 mmol/L and lactate of 2.92 mmol/L. Her blood glucose level was 96 mg/dL. Her white blood cell count was 7500/microL, neutrophil count was 4280/microL, and C-reactive protein level was 0.3 mg/dL; no abnormalities were noted on blood biochemistry and urinalysis. A cerebrospinal fluid test showed a cell count of 3/mm3, protein level of 50 mg/dL, and sugar level of 64 mg/dL. Bacterial cultures of blood, urine, spinal fluid, and nasal cavity were negative. Antigen tests for respiratory syncytial virus, SARS-CoV-2, and influenza viruses in the nasal fluid were negative. Chest radiography revealed no abnormalities (Figure 1).

Figure 1 Chest radiography

Chest radiography showed no abnormalities.

The patient was admitted to the hospital with a fever. At this point, the cause of the fever and tachypnea was not apparent. Three hours after admission, her respiratory rate decreased to 34/min but pCO2 increased to 87.4 mmHg with a pH of 7.051, indicating worsening respiratory acidosis. After an additional 4 h, pCO2 and pH recovered to normal levels without interventions; however, after another 15 h, CO2 retention, and respiratory acidosis reappeared without a marked increase in the respiratory rate. Uncontrolled respiration, persistent tachycardia, and severe coldness were deemed to indicate impairments of the central nervous system (CNS), including the respiratory center. Results of repeat cerebrospinal fluid tests were unremarkable; however, the HPeV genome was detected in a microarray assay. Brain magnetic resonance imaging (MRI) showed no abnormal findings except for subependymal cysts, which appeared to be congenital, as no changes were observed in follow-up MRIs (Figure 2).

Figure 2 Axial T1-weighted magnetic resonance imaging of the brain

Axial T1-weighted magnetic resonance imaging of the brain showed no abnormal findings except for subependymal cysts (indicated by a white arrow).

She was diagnosed with HPeV infection with a central ventilation defect. HFNC with ambient air was initiated based on the hypothesis that hypercapnia was due to reduced minute ventilation related to central ventilation defects. Two hours later, HFNC successfully reduced pCO2 to 54.5 mmHg and after another 2 hours, normalized it to 38.7 mmHg (Table 1).

Table 1 Blood gas values and vital parameters

Parameters	Time after admission, hours	
0	3	7	22	29	49	69	144	
Respiratory support	No	No	No	No	HFNC	HFNC	HFNC	No	
Blood gases	 	 	 	 	 	 	 	 	
pH	7.275	7.051	7.385	7.126	7.386	7.379	7.413	7.379	
pCO2, mmHg	54.0	87.4	38.1	73.3	38.7	43.6	43.5	38.5	
HCO3-, mmol/L	21.5	16.4	22.4	18.0	22.6	24.1	26.2	22.0	
Vital parameters	 	 	 	 	 	 	 	 	
SpO2, %	95	98	98	100	100	97	96	98	
Respiratory rate, min-1	50	34	45	38	28	30	38	47	
Heart rate, min-1	168	174	175	162	153	144	156	146	
Temperature, ℃	38.7	38.2	37.7	38.1	37.6	37.1	36.5	36.5	

Hypercapnia disappeared after the introduction of HFNC. The next day, her respiratory rate decreased to 30 breaths/min, the fever disappeared, and her general condition improved. Tachycardia resolved gradually and diminished on day 6 post-admission; subsequently, HFNC was discontinued.

Repeat MRI examinations one and three months later revealed no abnormalities in the brain. Currently, the patient is seven months old and without apparent motor or mental disabilities.

Discussion

Various microorganisms, including group B streptococcus and Escherichia coli, can be involved in fever in the neonatal period and early infancy. A notable infectious disease is the HPeV infection. In a prospective study, HPeV was identified in 19.6% of cases of fever of less than 3 months in which a pathogenic virus was identified [8]. The study also noted that HPeV tends to be detected from July to September, which applied to the present case.

HPeV infections exhibit diverse clinical presentations. Infections in neonates are symptomatic and present with fever, moodiness, feeding difficulties, tachycardia, abdominal distension, and erythematous palms [1]. Severe cases, such as septic shock syndrome or encephalitis, are particularly noteworthy. However, as a newly recognized infectious disease, epidemiological studies are in progress; hence, the risk factors for severe phenotypes of HPeV infections remain unclear. The present case had a typical clinical presentation of neonatal HPeV infection, except for hypercapnia without dyspnea, which to our knowledge, has not been reported previously.

HPeV rarely causes lower respiratory tract infections; however, the viral genome has been detected in the airways. Respiratory failure is a major cause of admission to the pediatric intensive care unit [9]. In a 10-year prospective observational study, respiratory failure was observed in two-thirds of patients with encephalitis [4]. Another study reported that more than half of patients with encephalitis had respiratory symptoms [10]. These findings suggest that respiratory symptoms may be a sign of severe HPeV infection and a reflection of extra-respiratory organ failure.

In this case, hypercapnia without hypoxia was observed. Direct HPeV involvement in respiratory areas, such as pneumonitis, was not evident on imaging, indicating that hypercapnia was caused by a reduction in ventilation volume. Decreased ventilation volume can be caused by a reduction in minute ventilation or frequency of ventilation. As the patient presented with tachypnea, decreased minute ventilation was considered the main cause of hypercapnia. Minute ventilation is influenced by respiratory muscle movement. As hypotonia is a symptom of HPeV infection [4], impaired movement of the respiratory muscles may cause hypercapnia. The respiratory center in the brainstem physiologically monitors blood pCO2 levels via chemoreceptors and is involved in respiratory control. Herein, the lack of respiratory upregulation under hypercapnia may have been a central ventilation defect. Although neonates with respiratory syncytial virus infection are prone to central apnea [11], the pathophysiologic mechanisms responsible for this symptom remain unclear. Some previous studies have shown that a prolonged laryngeal chemoreflex induced by disruptions in the neural control pathways, or an involvement of inflammation in the CNS, are the causes of apnea in neonates infected with this virus. As apnea attacks have already been reported in HPeV infections [12], a similar defect in respiratory control was considered in the present case.

HPeV has a high affinity for the CNS, and infections often result in encephalitis. In Japanese infants, encephalitis has been reported in >10% of infected cases [13]. The manifestations include convulsions, poor overall status, altered mental status, and signs of circulatory failure. MRI studies have shown diffusion abnormalities in the periventricular and subcortical white matter, corpus callosum, internal and external capsules, and pyramidal tracts [4]. Herein, no CNS involvement, such as encephalitis, was evident as per the manifestations and in imaging studies using MRI. However, based on the presence of a central ventilation defect, this case was deemed equivalent to encephalitis. Various electroencephalogram abnormalities, including subclinical seizures, are frequently observed in HPeV infection [14], regardless of whether abnormalities are observed in MRI findings [13]. In the present case, the transient central ventilation defect may have been caused by intermittent subclinical seizures at the respiratory center, resulting in recurrent hypercapnia.

The prognosis of parechovirus infection remains unclear, and there is no curative treatment for HPeV encephalitis; only symptomatic treatment is available for organ protection. In cases of convulsions and hypotension, anticonvulsants and pressure-raising drugs are administered, respectively. For enterovirus, which is also a picornavirus infection, the antiviral drug Pleconaril has been developed. Currently, there are no antiviral drugs for parechovirus; therefore, it is expected that antiviral drugs against parechovirus will be developed.

In the present case, hypercapnia and respiratory acidosis due to central ventilation defects were treated using forced inspiration with HFNC [15]. Ventilation is regulated at the respiratory center via signals provided by CO2-sensitive chemoreceptors or the vagal reflex from alveolar stretch receptors. As the regulation via CO2-sensitive chemoreceptors was deemed impaired herein, the Hering-Breuer reflex using the latter system was utilized; the Hering-Breuer reflex is initiated by lung expansion-excited stretch receptors [16]. Stimulation of the respiratory center via the vagal nerve shortens the inspiratory time and accelerates breathing frequency. Forced inspiration with HFNC successfully resolved central hypoventilation with hypercapnia. This confirms the usefulness of respiratory therapy via the physiological vagal reflex rather than forced mechanical ventilation.

Conclusions

Herein, our patient was diagnosed with HPeV infection based on typical presentation and a microarray analysis. Additionally, the patient exhibited hypercapnia without dyspnea, which, to our knowledge, is a novel presentation of the disease. The patient was successfully treated using HFNC.

In HPeV infections in neonates, impaired ventilation can be due to a CNS dysfunction that should not be overlooked. Based on the pathophysiological condition, appropriate therapeutic intervention is important to relieve the dysfunction and achieve neurological integrity.

We would like to thank Editage (www.editage.jp) for English language editing.

Disclosures

Author Contributions

Human subjects: Consent was obtained or waived by all participants in this study.

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following:

Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.

Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.

Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Concept and design:  Ryo Tahata, Akio Yamano, Masashi Zuiki, Yasunori Ishihara, Shinji Akioka

Acquisition, analysis, or interpretation of data:  Ryo Tahata, Akio Yamano, Masashi Zuiki, Yasunori Ishihara, Shinji Akioka

Drafting of the manuscript:  Ryo Tahata, Akio Yamano, Masashi Zuiki, Yasunori Ishihara, Shinji Akioka

Critical review of the manuscript for important intellectual content:  Ryo Tahata, Akio Yamano, Masashi Zuiki, Yasunori Ishihara, Shinji Akioka

Supervision:  Akio Yamano, Masashi Zuiki, Yasunori Ishihara, Shinji Akioka
==== Refs
References

1 Increased detection of human parechovirus infection in infants in England during 2016: epidemiology and clinical characteristics Arch Dis Child Ferreras Antolín L Kadambari S Braccio S Tang JW Xerry J Allen DJ Ladhani SN 1061 1066 103 2018 29871901
2 Pediatric parechovirus infections J Clin Virol Esposito S Rahamat-Langendoen J Ascolese B Senatore L Castellazzi L Niesters HG 84 89 60 2014 24690382
3 Severity of parechovirus infections in infants under 3 months of age and comparison with enterovirus infections: a French retrospective study Arch Pediatr Marchand S Launay E Schuffenecker I Gras-Le Guen C Imbert-Marcille BM Coste-Burel M 291 295 28 2021 33773893
4 Enterovirus and parechovirus meningoencephalitis in infants: a ten-year prospective observational study in a neonatal intensive care unit J Clin Virol Pietrasanta C Ronchi A Bassi L 105664 173 2024 38493709
5 Neurodevelopmental outcomes of newborns and infants with parechovirus and enterovirus central nervous infection: a 5-year longitudinal study Eur J Pediatr van Hinsbergh T Elbers RG Bouman Z van Furth M Obihara C 2005 2016 181 2022 35119491
6 Severe encephalitis: aetiology, management and outcomes over 10 years in a paediatric intensive care unit Arch Dis Child Palmas G Duke T 922 928 108 2023 37487693
7 Human parechovirus: an increasingly recognized cause of sepsis-like illness in young infants Clin Microbiol Rev Olijve L Jennings L Walls T 31 2018
8 Prevalence and characteristics of human parechovirus and enterovirus infection in febrile infants Pediatr Int Sano K Hamada H Hirose S 142 147 60 2018 29205679
9 Intensive care admissions for children with enterovirus and human parechovirus infections in the United Kingdom and the Republic of Ireland, 2010-2014 Pediatr Infect Dis J Braccio S Kapetanstrataki M Sharland M Ladhani SN 339 342 36 2017 27977558
10 Human parechovirus encephalitis in infants: a retrospective single-center study (2017-2022) Eur J Pediatr Alali M Tat K Hamilton S Streicher DA Carlucci JG 4457 4465 182 2023 37490108
11 Central nervous system alterations caused by infection with the human respiratory syncytial virus Rev Med Virol Bohmwald K Espinoza JA González PA Bueno SM Riedel CA Kalergis AM 407 419 24 2014 25316031
12 Human parechovirus type 3 infection: cause of apnea in infants born prematurely Pediatr Int Nirei J Aizawa Y Okazaki M 400 402 58 2016 27173420
13 HPeV3-associated acute encephalitis/encephalopathy among Japanese infants Brain Dev Abe Y Ohno T Matsumoto H 528 537 43 2021 33423809
14 EEG and clinical characteristics of neonatal parechovirus encephalitis Epilepsy Res Sirsi D Lowden A Dolce A Machie M Thomas J Joshi C 107143 192 2023 37084674
15 Non-invasive ventilation in neonates: a review of current literature Front Pediatr Ramaswamy VV Devi R Kumar G 1248836 11 2023 38089684
16 Learning to breathe: habituation of Hering-Breuer inflation reflex emerges with postnatal brainstem maturation Respir Physiol Neurobiol Dutschmann M Bautista TG Mörschel M Dick TE 44 49 195 2014 24566392
